Skip to content
2000

Advancements in Antileishmanial Drug Discovery: Targeting Druggable Pathways and Overcoming Treatment Challenges

image of Advancements in Antileishmanial Drug Discovery: Targeting Druggable Pathways and Overcoming Treatment Challenges
Preview this chapter:

Over the last decades, neglected tropical diseases (NTDs), especially leishmaniasis, have been the focus of several drug discovery programs. The identification of the pathogen druggable targets and the ability to map the differences between parasites and human enzymes have contributed to the increased interest in the development of new lead compounds. Despite this progress, there remain substantial gaps with respect to developing efficient medications that can be the foundation for surmounting the acquired resistance and overcoming treatment failure. With this background in mind, this chapter will discuss the validated drug targets with a special focus on the reported structural determinants of activity of novel antileishmanial agents. The aim is to introduce an updated overview of the medicinal chemistry aspects of leishmaniasis to the scientific community.

/content/books/9789815324785.chapter-2
dcterms_subject,pub_keyword
-contentType:Journal -contentType:Figure -contentType:Table -contentType:SupplementaryData
10
5
Chapter
content/books/9789815324785
Book
false
en
Loading
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test